JH reported receiving grants from Prati-Donaduzzi, travel support and personal fees from BioSynthesis Pharma Group, being a co-owner of a patent for fluorinated cannabidiol compounds (licensed to Phytecs), and having a patent pending for a cannabinoid-containing oral pharmaceutical composition outside the submitted work
Sadly, no
In other cities where the cost of a pack of cigarettes is much lower, it might not seem like such a great deal
We carry sweatpants, T-shirts, hats, sweatshirts, limited edition drops, and more displaying our cherished Zig-Zag man and text logo
CDI Query Trigger When a patients chart documents opioid use, opioid abuse, or is on Suboxone/buprenorphine but the diagnosis reads opioid use, unspecified (F11.90): Based on the patients history, current treatment with buprenorphine/naloxone, and clinical presentation, can you clarify whether the appropriate diagnosis is opioid dependence (F11.20), opioid dependence in early remission (F11.21), opioid abuse (F11.10), or opioid use unspecified (F11.90)
